The U.S. Medicare program’s decision to tightly limit coverage for the first drug meant to slow the course of Alzheimer’s disease has raised the stakes for companies trying to make the next one. https://t.co/7YWgZKmKll The U.S. Medicare Program’s Decision to Tightly Limit Coverage for the First Drug Meant … – Latest Tweet by Bloomberg — […]
\
\
